New DEA rules expand options for controlled substance disposal

Area of Science:

• Public Health
• Pharmaceutical Policy
• Drug Abuse Prevention

Background:

• Prescription drug abuse and overdose are significant public health issues in the United States.
• The accumulation of unused controlled substances poses risks of abuse, diversion, and accidental ingestion.

Purpose of the Study:

• To outline the implications of the United States federal Disposal of Controlled Substances Rule, effective October 9, 2014.
• To detail the Secure and Responsible Drug Disposal Act of 2010 (Disposal Act) and its role in mitigating prescription drug misuse.

Main Methods:

• The Disposal Act and associated Rule permit clinical areas to collect unused controlled substances.
• Eligible collection sites include retail pharmacies, hospitals/clinics with onsite pharmacies, and narcotic treatment programs.
• Collection methods involve controlled substance receptacles or mail-back programs, with a preference for receptacles due to onsite destruction requirements for mail-back programs.

Main Results:

• The regulations expand disposal methods and local participation in collecting unused controlled substances.
• Retail pharmacies and hospitals/clinics can place collection receptacles in long-term care facilities.
• Potential barriers to participation include costs, space limitations, and administrative burdens.

Conclusions:

• The Disposal Act and Rule aim to reduce the availability of unused controlled substances, thereby addressing prescription drug misuse.
• Increased accessibility to disposal methods is expected to enhance public safety.
• Addressing identified barriers is crucial for successful program implementation and widespread adoption.